Formula & Concentration

CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use

Manufacturer

Genzyme

Indications

CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.

Product Options

text

Package Size

NDC #

Presentation

11 mg

58468-0225-01

Vial

Shelf Life and Storage

Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.

Do not freeze.

Unopened vials may be stored in the original carton at room temperature up to 30°C (86°F) for a single period of up to 2 months.

Do not return CABLIVI to the refrigerator after it has been stored at room temperature.